Search results
4 Pharma, Biotech Stocks Poised to Beat Q1 Earnings Estimates
Zacks via Yahoo Finance· 1 year agoThe earnings season has just started for the drug/biotech sector, with bellwether Johnson & Johnson...
4 Biotech Stocks Likely to Outpace Q3 Earnings Estimates
Zacks via Yahoo Finance· 7 months agoAs we near the end of the ongoing earnings season, the scorecard for the Medical sector appears...
Biotech execs share the 3 most important steps companies can take to increase diversity and...
Business Insider via Yahoo News· 2 years agoPhoto_Concepts/Getty Images Nearly 8 out of 10 biotech companies say that diversity is a priority....
A Biotech Startup Used DMT to Successfully Treat Depression
The Daily Beast via Yahoo News· 1 year agoSkouatroulio / GettyA London biotech startup announced Wednesday that it had found success in...
Pharma CEOs are in wait-and-see mode on Mark Cuban's attempt to lower prices on generic drugs. 'It's...
Business Insider via Yahoo News· 1 year agoMark Cuban.Brian Snyder/Reuters The billionaire Mark Cuban wants to change the face of generic...
Royalty Pharma plc (NASDAQ:RPRX) Q3 2022 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 1 year agoRoyalty Pharma plc (NASDAQ:RPRX) Q3 2022 Earnings Call Transcript November 8, 2022 Royalty Pharma...
Cytokinetics (CYTK) Rises on Reports of Buyout by Novartis
Zacks via Yahoo Finance· 5 months agoShares of Cytokinetics, Incorporated CYTK increased 15.29% after reports of a plausible acquisition...
JPM24: Nvidia’s AI dreams, Sarepta’s rosy outlook and Jeff Jonas’ new job
BioPharma Dive via Yahoo Finance· 5 months agoBiotechnology investors and executives appeared eager to dive into this year’s J.P. Morgan...
Here's the Best Big Pharma Stock of the Decade so Far (and It's Not Even Close)
Motley Fool· 8 months agoThe overall stock market has performed well since 2020, despite the COVID-19 pandemic. As things...
Project Optimus: helping or hindering cancer drug development?
Clinical Trials Arena via Yahoo Finance· 1 month agoAlongside the multitude of guidance documents, recent years have seen the US Food and Drug...